A CXC chemokine with specificity for CXCR2 RECEPTORS. It has growth factor activities and is implicated as a oncogenic factor in several tumor types.
Chemokine Cxcl1 has been studied across 21 research domains including 🔬 Inflammation, 🔬 Oncology, 🛡️ Immunity, 💊 Pain, 🫘 Kidney. The primary research focus is 🔬 Inflammation with 43% of studies addressing this area.
This evidence profile for Chemokine Cxcl1 is generated deterministically from 246 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.